Cardioflow Medtech Repurchases 46,000 Shares for HK$509,600

Cardioflow Medtech Corporation (02291.HK) has repurchased a block of its own shares from the open market, according to a recent company announcement. The medical device manufacturer spent a total of HK$509,600 to buy back 46,000 shares on September 21.

Details of the Repurchase

The transaction was executed on the Hong Kong Stock Exchange, as detailed in a regulatory filing. The prices paid for the shares ranged from a low of HK$10.80 to a high of HK$11.18.

Key figures from the buyback include:

• Total Shares: 46,000
• Total Consideration: HK$509,600
• Price Per Share: HK$10.80 - HK$11.18

Ad

Market Context

Share repurchase programs are a common corporate action used to return capital to shareholders. By reducing the number of shares in circulation, a buyback can increase key financial metrics like earnings per share (EPS), which can be supportive of the stock price.

Investors often view buybacks as a signal of confidence from a company's management, implying that they believe the stock is undervalued at its current trading levels. This latest repurchase follows the company's stated buyback mandate.